An underground market for unapproved slimming medications is propelled by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.
Investigational Drug Acquiring Popularity Online
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to message these accounts directly for source information, while also receiving discount codes.
Active Commerce on Messaging Platforms
Separately, a robust market exists on messaging services, where communities with thousands of members share comparison images, administration instructions and claims of next-day UK delivery. Vendors promote the drug there before redirecting buyers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Healthcare Experts Voice Concerns
Nevertheless, physicians and pharmacists have warned that the sale of what remains an unlicensed medication in the UK is worrisome and could lead to individuals administering substances of uncertain source.
Some experts said the popularity for the experimental drug could be linked to the rising cost of approved weight loss products such as Mounjaro.
Legal Status and Enforcement
Marketing retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for human use under the British medical regulations.
Some content creators try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or imprisonment.
Service Response and Material Removal
Based on the social media company, the service has taken down violative content and prohibited related keywords and search suggestions. The organization stated it was dedicated to maintaining the service safe and allocating resources in enhancing enforcement strategies.
Online Marketplace Activities
Investigations also found groups with up to 9,000 participants marketing retatrutide using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, populated with photos of slimming results, positive reviews and detailed instructions for mixing or injecting at home.
After moments of entering one group, a vendor shared WhatsApp details, where the majority of purchases occur. The vendor provided an instruction manual and promised delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about body mass, health issues or past usage.
Item Details and Pricing
Within these communities, posts show dark colored packages with postal service stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with purified liquid, or pre-filled injectors usually sold at 160 pounds for 20mg. When questioned how much time a pen should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Service Moderation and Safety Actions
A spokesperson for the messaging service stated it regularly moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting materials they cannot confirm. Although the science behind this drug is sound, these digital products may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.
Her team has already seen individuals injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may subject users to potentially significant health risks”.
